Cancer Treatment Reviews
Volume 28, Issue 6 , Pages 275-290, December 2002

Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer☆

  • Fatima Cardoso
    • ,
  • Angelo Di Leo
    • ,
  • Martine J. Piccart

      Affiliations

    • Corresponding Author InformationCorrespondence to: Martine J. Piccart MD, PhD, Jules Bordet Institute, Chemotherapy Unit, Boulevard de Waterloo, 215 1000 Brussels, Belgium, Tel.: +32-2/541-32-06; Fax: +32-2/538-08-58

Chemotherapy Unit, Jules Bordet Institute, Brussels, Belgium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This paper is based on Dr Martine Piccart’s lecture at the Breast Cancer Education Section of the 2002 Meeting of the American Society of Clinical Oncology on “Controversies in Adjuvant Systemic Therapy of Breast Cancer”.

PII: S0305-7372(02)00091-9

Cancer Treatment Reviews
Volume 28, Issue 6 , Pages 275-290, December 2002

Article Tools

* Image Usage & Resolution